Navigation Links
Carnegie Mellon researchers to curb CO2 emissions
Date:4/2/2008

PITTSBURGHCarnegie Mellon Universitys Chris T. Hendrickson and H. Scott Matthews along with Alex Carpenter and Heather MacLean of the University of Toronto challenge Canadian officials to take the lead in eliminating dangerous carbon dioxide emissions that fuel global warming.

The researchers found that farming and power generation are the largest sources of Canadian carbon dioxide emissions per dollar output, according to research by Carnegie Mellons Green Design Institute and the University of Torontos Department of Civil Engineering.

This new modeling tool shows the dominance of electricity generation and it means that Canadians need to put a higher priority on our strategy for supplying our electricity needs, said MacLean, an associate professor at the University of Toronto. Burning more coal without carbon capture and storage will just increase our greenhouse gas emissions, taking us in the wrong direction.

To help keep the world on the right path for energy conservation and reduced emissions, the international Kyoto protocols of 1997 asked the industrialized nations of the world to reduce greenhouse gas emissions by 2012. Because burning coal creates power and releases gases that help drive global warming, scientists are trying to develop alternative fuels and solutions to stem the tide of global warming that threatens to disrupt lives everywhere.

We developed an environmental impact model that will enable Canadians to see what can be done to meet the Kyoto protocol as well as examining the environmental implications consumers choose to make, said Hendrickson, a professor in Carnegie Mellons Civil and Environmental Engineering Department and co-director of the Green Design Institute, a major interdisciplinary education and research effort to impact environmental quality through green design.

The environmental impact m
'/>"/>

Contact: Chriss Swaney
swaney@andrew.cmu.edu
412-268-5776
Carnegie Mellon University
Source:Eurekalert

Page: 1 2

Related biology news :

1. Carnegie Mellon researchers create invisibiity cloak
2. Carnegie Mellon receives $1.85 million
3. Carnegie Mellon scientists develop fluorescent proteins for live cell imaging, biosensor design
4. U. Mass Medical School and Carnegie announce licensing agreements with Oxford BioMedica
5. Novel mechanism for long-term learning identified by Carnegie Mellon researchers
6. Carnegie Mellon students win contest
7. Carnegie Mellon researchers to develop new drug delivery system
8. Mellon awards Carnegie Grant for Ecological Monitoring in South Africa
9. Carnegie Mellon, Pitt Team to study psychosocial stress
10. Carnegie Mellon scientist uses mass spectrometer to weigh virus particle, von Willebrand factor
11. Carnegie Mellon scientists investigate initial molecular mechanism that triggers neuronal firing

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)... Naturwissenschaften is publishing a special issu...ology" to commemorate Darwin,s On the Origin of Sp...r 1859. Guest editor and author of the lead articl...iology and evolutionary biology at the University ... issue are available free of charge until 30 Decem...
(Date:11/9/2009)..., November 09, 2009 / b3c newswire / - Today, T...venth Wave, an American organization for contract ...ies have signed a letter of intent with regard to ...M. The letter of intent proposes a collaboration i...or commercialization in North America. The TIM sys...
(Date:11/8/2009)...d. - Researchers at Purdue University have discove...ers in spinal cord injuries using nano-spheres tha...n accident. , The synthetic "copolymer micelles"...diameter, or roughly 100 times smaller than the di...een studying how to deliver drugs for cancer treat...
Breaking Biology News(10 mins):TNO and Seventh Wave sign letter of intent on joint preclinical pharmaceutical outsourcing services 2Findings show nanomedicine promising for treating spinal cord injuries 2Findings show nanomedicine promising for treating spinal cord injuries 3AcelRx Announces Perfect Performance of Handheld Component of ARX 01 Sufentanil NanoTab PCA System in a Phase 2 Study 52359 1AcelRx Announces Perfect Performance of Handheld Component of ARX 01 Sufentanil NanoTab PCA System in a Phase 2 Study 52359 2AcelRx Announces Perfect Performance of Handheld Component of ARX 01 Sufentanil NanoTab PCA System in a Phase 2 Study 52359 3Human Genome Sciences Announces New Order for Raxibacumab 28ABthrax 28TM 29 29 from U S Government 13137 1Human Genome Sciences Announces New Order for Raxibacumab 28ABthrax 28TM 29 29 from U S Government 13137 2Human Genome Sciences Announces New Order for Raxibacumab 28ABthrax 28TM 29 29 from U S Government 13137 3Human Genome Sciences Announces New Order for Raxibacumab 28ABthrax 28TM 29 29 from U S Government 13137 4Human Genome Sciences Announces New Order for Raxibacumab 28ABthrax 28TM 29 29 from U S Government 13137 5Human Genome Sciences Announces New Order for Raxibacumab 28ABthrax 28TM 29 29 from U S Government 13137 6Lexicon to Provide Clinical Pipeline Update and Report Second Quarter 2009 Financial Results on July 28 2009 13135 1Lexicon to Provide Clinical Pipeline Update and Report Second Quarter 2009 Financial Results on July 28 2009 13135 2
... nutritious and tasty, but don’t count on them to ...er Epidemiology, Biomarkers & Prevention, rese... Fred Hutchinson Cancer Research Center report tha...tomatoes, does not effectively prevent prostate ca...on between beta-carotene, an antioxidant related t...
... Universitat Autònoma de Barcelona (UAB), in coope...-chemical biosensor which detects the presence, in...he most widely used herbicides in agriculture and ...vironment- as well as antibiotics in food. The bio...the expensive laboratory methods which are used to...
...ar symmetrical at first glance, but we,re full of ... up a pencil or throw a baseball, to where languag... our internal organs, humans are a glut of asymmet...norhabditis elegans has nerves on its left and rig...ndedness, the determination of which nerves develo...
Other Biology News:No magic tomato? Study breaks link between lycopene and prostate cancer prevention 2A new portable biosensor detects traces of contaminants in food more quickly and cheaply 2Left-right wiring determined by neural communication in the embryonic worm 2
(Date:11/6/2009)... CALGARY, Nov. 6 /PRNewswire-FirstCall/ - Oncolyti...s" or the "Company") today announced updated resul...) in patients with sarcomas metastatic to the lung...ctive Tissue Oncology Society Meeting held in Miam...ster presentation, entitled "A Phase II Study of I...
(Date:11/6/2009)... The agenda for Arrowhead&rsqu...ence, which is set to take place on February 22-24...s three day conference we will highlight key issue...kers to share their experiences. , ... -- The agenda for Arrowhead’s 2010 Persona...
(Date:11/5/2009)... GAITHERSBURG, Md., Nov. 5 /PRNewswire-FirstCall/ ...ts financial results for the third quarter ended S...3.6 million ($0.04 per share) for the three months...f $6.8 million ($0.08 per share) in the comparable...ber 30, 2009, GenVec,s net loss was $14.1 million ...
(Date:11/5/2009)... PARSIPPANY, N.J., Nov. 5 DSM Phar...de a manufacturing alliance with Galenix, Saint Je...d commercial scale manufacturing partner for Galen...M and Galenix will collaborate on business develop...ery technologies, based on the strength of Galenix...
Breaking Biology Technology:Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3
... Calif., July 31 Alsius Corporation,(Nasdaq: ALU...ture,management (IVTM(TM)) therapies for criticall...a conference call to discuss the Company,s,second ...ll Worthen,president and CEO, will host the call b...ern Time) on Thursday, August 7. A press release f...
... Colo., July 31 Sierra Neuropharmaceuticals,Inc.,...-brain treatment of,neurological diseases, announc...ing. Co-leads in the funding were HealthCare Ventu...tners. Other investors include High Country,Ventur...etary drug development process that makes use of,s...
...OWN, Pa., July 31 The Quigley,Corporation (Nasdaq...,operations of $2.1 million, for the second quarte...orted for the second quarter ended June 30,2007. F...ere $7.4 million,compared to $8.4 million reported...t sales were influenced by distribution changes an...
Other Biology Technology:Alsius Corporation to Host Second Quarter 2008 Financial Results Conference Call on August 7 2Sierra Neuropharmaceuticals Completes $21.5-Million Series A Funding Round 2Sierra Neuropharmaceuticals Completes $21.5-Million Series A Funding Round 3The Quigley Corporation Reports Second Quarter 2008 Results: Continues Investment in Pharmaceutical R&D Future 2The Quigley Corporation Reports Second Quarter 2008 Results: Continues Investment in Pharmaceutical R&D Future 3The Quigley Corporation Reports Second Quarter 2008 Results: Continues Investment in Pharmaceutical R&D Future 4The Quigley Corporation Reports Second Quarter 2008 Results: Continues Investment in Pharmaceutical R&D Future 5The Quigley Corporation Reports Second Quarter 2008 Results: Continues Investment in Pharmaceutical R&D Future 6
Rabbit Anti-Human DNase II Polyclonal Antibody, Unconjugated from Calbiochem
BD BioCoat Poly-D-Lysine 60 mm Culture Dishes from BD Biosciences - Discovery Labware
BD BioCoat Collagen I 60 mm Culture Dishes from BD Biosciences - Discovery Labware
Corning C ulture Dishes,100X20 mm,55Cm2,Sterile,6-Pack Carrier (6Pks Of 10 Dishes) from Sigma-Aldrich
Biology Products: